Literature DB >> 20190567

Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristics.

Luis Del Valle1, Sergio Piña-Oviedo2, Georgina Perez-Liz2, Brian J Augelli3, S Ausim Azizi3, Kamel Khalili4, Jennifer Gordon2, Barbara Krynska3.   

Abstract

There is now accumulating evidence showing that some tumors may arise from transformed stem cells. In this study we demonstrate that adult bone marrow- derived mesenchymal stem cells (MSCs) undergo neoplastic transformation induced by the human polyomavirus JCV, early protein, T-antigen, and are tumorigenic when transplanted into the flanks of Nude mice as compared to non-transformed MSCs. Histologically, the tumors are heterogeneous with mesenchymal and neural crest characteristics as evidenced by expression of the neural crest markers p75, SOX-10, and S-100, with populations of tumor cells exhibiting characteristics of primitive neuroectodermal cells. In addition, a subset of T-antigen positive tumor cells exhibit a high proliferation index as detected by Ki-67 labeling, and co-express CD133, a marker which is expressed on cancer stem cells. These results show that tumors with neuroectodermal characteristics may arise from transformation of MSCs, a globally accessible adult stem cell with multipotent differentiation capacity. In light of earlier reports on the association of JCV with a broad variety of human tumors, our data suggests that T-antigen transformation of adult stem cells with a multipotent capacity can serve as a possible common origin for some of these cancers, and offers a novel model for oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190567      PMCID: PMC2921558          DOI: 10.4161/cbt.9.4.10653

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  44 in total

1.  Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells.

Authors:  D C Colter; I Sekiya; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

2.  Isolation of a stem cell for neurons and glia from the mammalian neural crest.

Authors:  D L Stemple; D J Anderson
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

Review 3.  Regulatory mechanisms in stem cell biology.

Authors:  S J Morrison; N M Shah; D J Anderson
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

Review 4.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

5.  Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  S A Houff; E O Major; D A Katz; C V Kufta; J L Sever; S Pittaluga; J R Roberts; J Gitt; N Saini; W Lux
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

6.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; R J Eckroade; B H Dessel
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

7.  High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.

Authors:  E M Schneider; K Dörries
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

8.  Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma.

Authors:  Luis Del Valle; Jennifer Gordon; Sahnila Enam; Serena Delbue; Sidney Croul; Selvajothi Abraham; Sujatha Radhakrishnan; Martha Assimakopoulou; Christos D Katsetos; Kamel Khalili
Journal:  J Natl Cancer Inst       Date:  2002-02-20       Impact factor: 13.506

9.  Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.

Authors:  Rossella Galli; Elena Binda; Ugo Orfanelli; Barbara Cipelletti; Angela Gritti; Simona De Vitis; Roberta Fiocco; Chiara Foroni; Francesco Dimeco; Angelo Vescovi
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

Review 10.  Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  E O Major; K Amemiya; C S Tornatore; S A Houff; J R Berger
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

View more
  5 in total

Review 1.  Immune surveillance and response to JC virus infection and PML.

Authors:  Sarah Beltrami; Jennifer Gordon
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

2.  In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrow.

Authors:  Sabine Wislet-Gendebien; Christophe Poulet; Virginie Neirinckx; Benoit Hennuy; James T Swingland; Emerence Laudet; Lukas Sommer; Olga Shakova; Vincent Bours; Bernard Rogister
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

3.  Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen.

Authors:  Jennifer Gordon; Ilker K Sariyer; Marisol De La Fuente-Granada; Brian J Augelli; Jessica Otte; S Ausim Azizi; Shohreh Amini; Kamel Khalili; Barbara Krynska
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

4.  Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction model.

Authors:  Yuan Tang; Xiaoliang Gan; Rabe'e Cheheltani; Elizabeth Curran; Giuseppina Lamberti; Barbara Krynska; Mohammad F Kiani; Bin Wang
Journal:  Nanomedicine       Date:  2014-06-15       Impact factor: 5.307

5.  Novel polyomavirus associated with brain tumors in free-ranging raccoons, western United States.

Authors:  Florante N Dela Cruz; Federico Giannitti; Linlin Li; Leslie W Woods; Luis Del Valle; Eric Delwart; Patricia A Pesavento
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.